NANTAHALA CAPITAL MANAGEMENT LLC
Q3 2026 Form 13-F

NEW CANAAN, CONNECTICUT
CIK 0001472322 · CRD 158081 · SEC-registered investment adviser
$3.2B Reported Value Total

NANTAHALA CAPITAL MANAGEMENT, LLC reports 11 total accounts under management (AUM). There are 11 discretionary accounts valued at $3,114,082,769, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
SEC Registered Discretionary Manager
Private funds (Form ADV)
12 funds · $3.0B gross asset value
Hedge Fund: $3.0B
Source: Form ADV filed 2026-09-14
Reported value
$3.2B
Quarter over quarter
-3.4%
Holdings
143
Top-10 concentration
37.4%

Key People

Form ADV owners & control persons
Steven Harris Bloom
MANAGER
Wilmot B. Harkey
MANAGING MEMBER
Daniel J. Mack
MANAGING MEMBER

Filing Navigation

13F Metrics

Loading 13F Metrics

Q3 2026 13F record

Q3 2026 13F filing summary

Q3 2026 Form 13F portfolio summary
Period of report September 30, 2026
Filed November 13, 2026
Form 13F-HR
Reported value $3.2B
Positions 143
Change in reported value +4.9%
New positions 32
Exited positions 20
Position turnover 31.9%
Top-10 concentration 37.4%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
143 $3.2B
Q2 2026 13F
Filed Aug 14, 2026
131 $3.0B
Q1 2026 13F
Filed May 15, 2026
129 $2.7B
Q4 2025 13F
Filed Feb 13, 2026
132 $3.0B
Q3 2025 13F
Filed Nov 14, 2025
131 $2.9B
Q2 2025 13F
Filed Aug 14, 2025
138 $2.6B
Q1 2025 13F
Filed May 15, 2025
129 $2.5B
Q4 2024 13F
Filed Feb 14, 2025
122 $2.3B
Q3 2024 13F
Filed Nov 14, 2024
124 $2.0B
Q2 2024 13F
Filed Aug 14, 2024
116 $1.7B
Q1 2024 13F
Filed May 15, 2024
110 $1.8B
Q4 2023 13F
Filed Feb 14, 2024
109 $1.7B
Q3 2023 13F
Filed Nov 14, 2023
112 $1.2B
Q2 2023 13F
Filed Aug 14, 2023
108 $1.0B
Q1 2023 13F
Filed May 15, 2023
109 $1.3B
Q4 2022 13F
Filed Feb 14, 2023
103 $1.5B
Q3 2022 13F
Filed Nov 10, 2022
102 $1.5B
Q2 2022 13F
Filed Aug 15, 2022
104 $2.0B
Q1 2022 13F
Filed May 13, 2022
105 $2.3B
Q4 2021 13F
Filed Feb 14, 2022
107 $2.8B

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q3 2026

Largest Q3 2026 13F positions by reported value
# Holding Reported value % of portfolio
1 IWM P ISHARES TR $500.2M 15.82%
2 XBI P SPDR SERIES TRUST $110.4M 3.49%
3 VTRS C VIATRIS INC $88.6M 2.8%
4 BVS BIOVENTUS INC $87.5M 2.77%
5 PTON C PELOTON INTERACTIVE INC $85.2M 2.69%
6 TBBK BANCORP INC DEL $70.6M 2.23%
7 KRE P SPDR SERIES TRUST $69.4M 2.2%
8 EW P EDWARDS LIFESCIENCES CORP $69.1M 2.18%
9 HLF C HERBALIFE LTD $52.2M 1.65%
10 EOLS EVOLUS INC $50.0M 1.58%
11 PTON PELOTON INTERACTIVE INC $45.1M 1.43%
12 ETON ETON PHARMACEUTICALS INC $45.1M 1.43%
13 HGV HILTON GRAND VACATIONS INC $44.2M 1.4%
14 AMRX AMNEAL PHARMACEUTICALS INC $42.6M 1.35%
15 LBRX LB PHARMACEUTICALS INC $41.2M 1.3%
16 PRAX P PRAXIS PRECISION MEDICINES I $40.9M 1.29%
17 HGV C HILTON GRAND VACATIONS INC $40.7M 1.29%
18 RARE C ULTRAGENYX PHARMACEUTICAL IN $37.6M 1.19%
19 SVRA SAVARA INC $36.8M 1.16%
20 FOSL FOSSIL GROUP INC $36.2M 1.14%

Values as reported on the Q3 2026 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Similar Managers

Finding Similar Managers

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings